AR025198A1 - Compuestos para el tratamiento de trastornos infecciosos y del sistema inmune y metodos para su uso - Google Patents
Compuestos para el tratamiento de trastornos infecciosos y del sistema inmune y metodos para su usoInfo
- Publication number
- AR025198A1 AR025198A1 ARP000103531A ARP000103531A AR025198A1 AR 025198 A1 AR025198 A1 AR 025198A1 AR P000103531 A ARP000103531 A AR P000103531A AR P000103531 A ARP000103531 A AR P000103531A AR 025198 A1 AR025198 A1 AR 025198A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- compounds
- methods
- immune system
- infectious disorders
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 210000000987 immune system Anatomy 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000187644 Mycobacterium vaccae Species 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion presenta polipéptidos que comprenden un epítopo inmunogénico de una proteína de M. vaccae, polinucleotidos que codifican dichospolipéptidos y proteínas de fusion que comprenden por lo menos uno de tales polipéptidos, junto conc onstrucciones de ADN que comprende por lo menos unpolinucleotido de la presente invencion. Las composiciones que comprenden dichos polipéptidos, polinucleotidos, proteínas de fusion y/o construcciones de ADNse pueden emplear en el tratamiento deenfe rmedades infecciosas y trastornos inmunes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/351,348 US6436898B1 (en) | 1999-07-12 | 1999-07-12 | Compounds for treatment of infectious and immune system disorders and methods for their use |
US09/450,072 US6358734B1 (en) | 1999-07-12 | 1999-11-29 | Compounds for treatment of infectious and immune system disorders and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
AR025198A1 true AR025198A1 (es) | 2002-11-13 |
Family
ID=23380534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000103531A AR025198A1 (es) | 1999-07-12 | 2000-07-10 | Compuestos para el tratamiento de trastornos infecciosos y del sistema inmune y metodos para su uso |
Country Status (5)
Country | Link |
---|---|
US (2) | US6436898B1 (es) |
KR (1) | KR20020025187A (es) |
CN (1) | CN1800210A (es) |
AR (1) | AR025198A1 (es) |
DE (1) | DE60037195T2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2383496A1 (en) * | 1999-07-12 | 2001-01-18 | Genesis Research & Development Corporation Limited | Compounds for treatment of infectious and immune system disorders and methods for their use |
CN107099603A (zh) * | 2017-05-31 | 2017-08-29 | 成都克里斯博生物科技有限公司 | 肿瘤免疫t细胞检测试剂盒和检测方法 |
-
1999
- 1999-07-12 US US09/351,348 patent/US6436898B1/en not_active Expired - Fee Related
- 1999-11-29 US US09/450,072 patent/US6358734B1/en not_active Expired - Fee Related
-
2000
- 2000-07-10 KR KR1020027000294A patent/KR20020025187A/ko not_active Application Discontinuation
- 2000-07-10 CN CNA2005101269980A patent/CN1800210A/zh active Pending
- 2000-07-10 AR ARP000103531A patent/AR025198A1/es unknown
- 2000-07-10 DE DE60037195T patent/DE60037195T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6358734B1 (en) | 2002-03-19 |
CN1800210A (zh) | 2006-07-12 |
KR20020025187A (ko) | 2002-04-03 |
DE60037195D1 (de) | 2008-01-03 |
DE60037195T2 (de) | 2008-10-02 |
US6436898B1 (en) | 2002-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2059565T3 (es) | Virus mva de la vacuna, recombinante. | |
AR109680A1 (es) | Proteínas recombinantes y sus usos | |
BR7908410A (pt) | Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos | |
NO20012812L (no) | Vaksinesammensetning og vaksine samt anvendelse av polypeptid og polynukletid | |
AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
DK0587780T3 (da) | Smitstof, som forårsager Mystery Swine Disease, vaccinepræparater og diagnostiske sæt | |
PT851927E (pt) | Compostos para imunoterapia e diagnostico de tuberculose | |
UY26783A1 (es) | Antígenos de estreptococo. | |
WO2007015704A3 (en) | Modified bacteriophage vectors and uses thereof | |
BRPI0411321A (pt) | vetor viral associado a adenovìrus, composição farmacêutica e método para tratar doença de alzheimer, e, uso do vetor viral associado a adenovìrus | |
NO20075900L (no) | Forbindelser for immunterapi og diagnose av tuberkulose og metoder for deres anvendelse | |
DE69836588D1 (de) | Tuberkulose impfstoff | |
WO1999042076A3 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
WO2007016598A3 (en) | Influenza vaccine compositions and methods of use thereof | |
CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
ATE520713T1 (de) | Identifizierung und veränderung von immundominanten polypeptidepitopen | |
FI945221A0 (fi) | Yhdistelmä-DNA-molekyylejä, jotka koodittavat aminopeptidaasientsyymejä, ja niiden käyttö rokotteiden valmistamiseksi matotartuntoja vastaan | |
WO2002024739A3 (en) | Spas-1 cancer antigen | |
AR053372A1 (es) | Proteinas inmunologicas de lawsonia intracellularis | |
AR035077A1 (es) | Polipeptidos de neublastina variante, proteinas de fusion, acidos nucleicos, vectores, celulas hospedadoras, metodos para producir dichos polipeptidos, dimeros, conjugados, composiciones farmaceuticas y uso de dichos polipeptidos en la preparacion de medicamentos | |
ES2069742T3 (es) | Proteina de la capsida del calicivirus felino y secuencia nucleotida. | |
WO2001021807A8 (en) | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof | |
AU7312801A (en) | Compositions and methods for the diagnosis and treatment of herpes simplex virusinfection | |
DK1219301T3 (da) | Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner | |
AR025198A1 (es) | Compuestos para el tratamiento de trastornos infecciosos y del sistema inmune y metodos para su uso |